Sign in

CIK 0001479615 · Non-accelerated filer<br>Smaller reporting company

Silence Therapeutics plc

Sign in to watch
Tickers
SLN SLNCF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
Incorporated
United Kingdom
Entity type
operating
Phone
44-0-20-3457 6900
Business address
12 HAMMERSMITH GROVE, OFFICE 205, LONDON, United Kingdom, W6 7AP

Securities

  • SLN American Depository Share Nasdaq
  • SLNCF Common stock OTC
  1. SCHEDULE 13D/A Stake Beneficial Ownership Report
  2. 6-K Event Report of Foreign Issuer
  3. 6-K Event Report of Foreign Issuer
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G/A Stake Amended Statement of Ownership
  6. 6-K Event Report of Foreign Issuer
  7. SC 13G/A Stake Amended Statement of Ownership
  8. F-3ASR Offering Registration Statement
  9. 6-K Event Report of Foreign Issuer
  10. SC 13G/A Stake Amended Statement of Ownership
  11. 6-K Event Report of Foreign Issuer
  12. 6-K Event Report of Foreign Issuer
  13. 6-K Event Report of Foreign Issuer
  14. 6-K Event Report of Foreign Issuer
  15. 6-K Event Report of Foreign Issuer
  16. EFFECT Other Notice of Effectiveness
  17. 424B3 Offering Prospectus
  18. CORRESP Other Correspondence Between Filers and SEC Staff
  19. UPLOAD Other SEC-generated Letter
  20. DEL AM Other DEL AM

Page 7 of 14 · 278 filings